Skip to main content
Clinical Trials/NCT00795951
NCT00795951CompletedPhase 4

Clinical Evaluation of T.R.U.E. TEST® Panel 1.1, 2.1 and 3.1: in Children and Adolescents

Allerderm2 sites in 1 country102 target enrollmentStarted: November 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
102
Locations
2
Primary Endpoint
Positive Reactions: Neomycin Sulfate

Study Overview

Brief Summary

Open, prospective, single-site, non-randomized study of the efficacy and safety of T.R.U.E. TEST allergens in children and adolescents ages 6-18.

Detailed Description

Three T.R.U.E. TEST panels (1.1, 2.1 and 3.1) containing 28 allergens and a negative control will be applied to the skin on the subject's back and worn for approximately 48 hours. Patch test site skin reactions will be evaluated at days 2, 3 (+1), 7 and 21 following panel application

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
6 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Symptoms and history potentially consistent with allergic contact dermatitis based on symptoms and clinical history (i.e., subjects are visiting the clinic/physician to diagnose, treat or resolve this condition).
  • Children and adolescents 6 to 18 years of age, and in general good health.
  • Adolescent females 15 years of age or older (or with menarche) must consent to a urine pregnancy test; urine test results must be negative for study inclusion.
  • Informed consent must be signed and understood by subject. If underage, informed consent must be signed and understood by parent or legal guardian, consistent with all institutional, local and national regulations.

Exclusion Criteria

  • Topical corticosteroid treatment during the last 7 days on or near the test area.
  • Systemic treatment with corticosteroids or other immunosuppressive during the last 7 days.
  • Subjects currently receiving (or received during the previous 3 weeks) other investigational drugs, treatments or devices, or participating in another clinical study.
  • Treatment with ultraviolet (UV) light (including tanning) during the previous 3 weeks.
  • Acute dermatitis outbreak or dermatitis on or near the test area on the back.
  • Subjects unable to comply with activity restrictions (e.g., protecting test panels from excess moisture due to showering or vigorous activity).
  • Subjects unable or unwilling to comply with multiple return visits.
  • Female subjects 15 years of age (or with onset of menarche) and older unable to consent to a urine pregnancy test, or those with a positive pregnancy test.

Outcomes

Primary Outcomes

Positive Reactions: Neomycin Sulfate

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions (score of 1+, 2+ or 3+) at visit 3 and/or visit 4

Positive Reactions: Paraben Mix

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Balsam of Peru

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: p-Phenylenediamine

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Cobalt Dichloride

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Thimerosal

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Thiuram Mix

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Wool Alcohol

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Caine Mix

Time Frame: Visit 3: 72-96 hours after patch application, Visit 4: 1 week after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Negative Control

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4.

Positive Reactions: Epoxy Resin

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Carba Mix

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Mercaptobenzothiazole

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Diazolidinyl Urea

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Potassium Dichromate

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Ethylenediamine Dihydrochloride

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days week after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Cl+Me-Isothiazolinone

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Formaldehyde

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Tixocortol-21-pivalate

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions at visit 3 and/or visit 4

Positive Reactions: Nickel Sulfate

Time Frame: Visit 3: 3-4 after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions (score of 1+, 2+ or 3+) at visit 3 and/or visit 4

Positive Reactions: Fragrance Mix

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Colophony

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: P-tert Butylphenol Formadehyde Resin

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Black Rubber Mix

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Quaternium-15

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Mercapto Mix

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions at visit 3 and/or visit 4

Positive Reactions: Budesonide

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Positive Reactions: Imidazolidinyl Urea

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions at visit 3 and/or visit 4

Positive Reactions: Quinoline Mix

Time Frame: Visit 3: 3-4 days after patch application, Visit 4: 7 days after patch application

Number of subjects with positive reactions recorded at visit 3 and/or visit 4

Secondary Outcomes

  • Late Reactions: Wool Alcohol(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Potassium Dichromate(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Tixocortol-21-pivalate(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Epoxy Resin(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Carba Mix(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Black Rubber Mix(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Persistent Reactions: Quaternium-15(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Black Rubber Mix(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Late Reactions: Neomycin Sulfate(Visit 4: 7 days after patch application)
  • Late Reactions: Colophony(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Cl+Me-Isothiazolinone(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Mercapto Mix(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Budesonide(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Persistent Reactions: Fragrance Mix(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Colophony(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Negative Control(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Balsam of Peru(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Late Reactions: Mercaptobenzothiazole(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: p-Phenylenediamine(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Formaldehyde(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Thimerosal(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Persistent Reactions: Nickel Sulfate(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Wool Alcohol(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Potassium Dichromate(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Ethylenediamine Dihydrochloride(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Late Reactions: Nickel Sulfate(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Caine Mix(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Fragrance Mix(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Quaternium-15(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Thiuram Mix(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Diazolidinyl Urea(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Persistent Reactions: Caine Mix(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Paraben Mix(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Epoxy Resin(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: p-Phenylenediamine(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Formaldehyde(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Late Reactions: Paraben Mix(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Negative Control(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Balsam of Peru(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Ethylenediamine Dihydrochloride(Visit 4: 7 days week after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Cobalt Dichloride(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: P-tert Butylphenol Formadehyde Resin(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Imidazolidinyl Urea(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Late Reactions: Quinoline Mix(Visit 4: 7 days after patch application or Visit 5: 21 days after patch application)
  • Persistent Reactions: Cobalt Dichloride(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: P-tert Butylphenol Formadehyde Resin(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Carba Mix(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Cl+Me-Isothiazolinone(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Mercapto Mix(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Thimerosal(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Thiuram Mix(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Imidazolidinyl Urea(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Quinoline Mix(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Neomycin Sulfate(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Diazolidinyl Urea(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Budesonide(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Subject Reported Itching and Burning(Visit 2 (day 1) following to panel removal.)
  • Persistent Reactions: Tixocortol-21-pivalate(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Persistent Reactions: Mercaptobenzothiazole(Visit 3: 3-4 days after patch application through Visit 4: 7 days after patch application and/or Visit 5 21 days after patch application)
  • Panel Adhesion Evaluation(Visit 2 (day 1) prior to panel removal.)
  • Panel Irritation(Visit 2 (day 1) following to panel removal.)

Investigators

Sponsor
Allerderm
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials